Form 4: Director Brian Mark Stevens Receives Genpact RSU Grant

Director Brian Mark Stevens was granted 6,521 restricted share units as part of the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Summary

• Director Brian Mark Stevens acquired 6,521 restricted share units (RSUs) on April 23, 2026.
• The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Following this transaction, the director's total beneficial ownership of common shares is 36,619.
• The grant is subject to continued service requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon the director's continued service to the company.

Future Outlook

The RSUs are scheduled to vest on December 31, 2026, and will be settled in common shares on December 31, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder interests in the IT services and consulting sector.

Comparison to Industry Standards

• The use of restricted share units (RSUs) as a component of director compensation is consistent with standard practices among large-cap technology and professional services firms.
• The vesting schedule of approximately 20 months is typical for director equity retention programs.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation grant.

Next Steps

• Vesting of RSUs on December 31, 2026.
• Settlement of RSUs into common shares on December 31, 2027.

Key Dates

Keywords

Genpact, Form 4, Insider Trading, Director Compensation, Equity Incentive Plan